Clinical Trial

Peri-implant Tissues on the Galimplant Anti-rotational Slim Abutment.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A dental implant is an alloplastic material surgically inserted in a residual bone ridge, mainly with a prosthetic foundation. Nowadays the most widely used implants and with a higher degree of scientific evidence are the titanium root-form endosseous implants. In addition to the root component, the prosthodontic systems that allow the crown to be connected to the implant are very important. The aim of this project is to compare a classic anti-rotational straight esthetic multi-position attachment with the new anti-rotational straight esthetic slim multi-position abutment, both placed at the time of implant surgery. A multicenter randomized single-blind (for the patient) split-mouth randomized clinical trial will be performed to compare the composition, distribution and structure of the peri-implant tissues around the classic straight (control) and Slim (test) intermediate prosthetic abutments of the manufacturer Galimplant (Sarria; Lugo, Spain). The objective is to study which abutment design obtains a better biological seal from the clinical and histomorphometric point of view. For this purpose, 60 dental implants will be placed for the replacement of bilateral posterior absences in 30 patients attending the Master of Oral Medicine, Oral Surgery and Implantology of the University of Santiago de Compostela, Spain.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-11; most recent amendment 2025-03-24.
Status change: Recruiting → Active, Not Recruiting 2023-05-11
Status change: Not Yet Recruiting → Recruiting 2022-02-21
Trial Details
NCT Number NCT05118815
Lead Sponsor University of Santiago de Compostela
Collaborators: University of Salamanca, University of Valencia, Universidad de Murcia, Health Research Institute of Santiago
Conditions Teeth Absent, Tooth-loss, Tooth Extraction, Dental Implant
Enrollment 5 participants
Start Date 2022-02-21
Primary Completion 2023-05-02 (estimated)
Study Completion 2025-07-29 (estimated)
Updated on ClinicalTrials.gov 2025-03-28